The Mario Negri Institute for Pharmacological Research, a PERMIT consortium member, has published an article in its online magazine on personalised medicine. It provides an overview, in lay terms of the basis of personalised medicine, its fields of application, its current challenges, its costs and the ethical questions it raises. The article also highlights European initiatives on personalised medicine such as the ICPerMed and the PERMIT Project and provides outlooks on the future of personalised medicine. Read the full article here (article in Italian).
A new publication about robust & reproducible preclinical research in #PersonalisedMedicine has been published in BMCMedicine. Among the authors are EATRIS staff & institutions members. Congrats to all involved. 👉Find out more hereatris.eu/news/new-publi…w#PERMITprojectect https://t.co/kp46SdWB9G
Catch up on your reading! The #PERMITproject has a new publication! twitter.com/ECRIN_ERIC/sta…
New #PERMITProject publication: Recommendations for robust & reproducible preclinical research in personalised medicine. 15 recommendations are presented aiming to improve the robustness of preclinical methods in translational research for PM. permit-eu.org/publications https://t.co/zAS8pYOlOm